Subsequent events

9 Months Ended

Sep. 30, 2026

Subsequent Events [Abstract]

Subsequent events [Text Block]

16. Subsequent events

Share Consolidation:

At the Company's 2026 Annual General meeting and Special Meeting held on June 3, 2026, the Company's shareholders approved a proposal authorizing the Company's board of directors to effect a consolidation of the common shares at a ratio of up to 50 to 1. Subsequently, the Company's board of directors approved a share consolidation of the Company's common shares on a 50 to 1 basis, which became effective on October 12, 2026.

All share and per share amounts in the accompanying unaudited condensed consolidated financial statements and related notes have been retroactively adjusted to reflect the share consolidation for all periods presented.

ATM Financing:

Subsequent to the period ended September 30, 2026, the Company completed sales under its ATM pursuant to which it issued 41,200 common shares for gross proceeds of approximately $240,013 or approximately $232,812 after incurring commissions payable to the Agents.

Proposed SkinJect Business Combination:

On November 4, 2026, the Company announced that SkinJect entered into a non-binding letter of intent with an undisclosed special purpose acquisition company for a proposed business combination involving SkinJect (the “Business Combination”) and concurrent equity financing. There can be no assurance that definitive agreements relating to the Business Combination will be signed, that the equity financing will be secured or that the transaction will be completed.